Graham Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Buy |
+143,035
| New | +$491K | 0.01% | 797 |
|
|
2025
Q1 | – | Sell |
-103,610
| Closed | -$304K | – | 1220 |
|
|
2024
Q4 | $304K | Buy |
+103,610
| New | +$304K | ﹤0.01% | 903 |
|
|
2024
Q2 | – | Sell |
-47,551
| Closed | -$215K | – | 979 |
|
|
2024
Q1 | $215K | Sell |
47,551
-27,606
| -37% | -$125K | ﹤0.01% | 853 |
|
|
2023
Q4 | $429K | Sell |
75,157
-105,232
| -58% | -$601K | 0.01% | 609 |
|
|
2023
Q3 | $830K | Buy |
180,389
+108,060
| +149% | +$497K | 0.02% | 404 |
|
|
2023
Q2 | $467K | Sell |
72,329
-401,921
| -85% | -$2.6M | 0.01% | 563 |
|
|
2023
Q1 | $3.58M | Buy |
474,250
+325,051
| +218% | +$2.45M | 0.11% | 119 |
|
|
2022
Q4 | $1.51M | Sell |
149,199
-254,972
| -63% | -$2.58M | 0.05% | 376 |
|
|
2022
Q3 | $4M | Buy |
404,171
+340,732
| +537% | +$3.37M | 0.16% | 65 |
|
|
2022
Q2 | $675K | Buy |
+63,439
| New | +$675K | 0.03% | 560 |
|
|
2022
Q1 | – | Sell |
-25,727
| Closed | -$367K | – | 866 |
|
|
2021
Q4 | $367K | Buy |
+25,727
| New | +$367K | 0.02% | 246 |
|